Skip to main content

ACR Convergence 2022 Main banner

Schedule at a Glance

Scientific Session

Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma

Session: ACR Crosstalk: Difficult to Treat Pediatric Uveitis

Are JAK Inhibitors the Future Therapy for JIA-Associated Uveitis?

Sunday, November 13, 2022

11:00 AM – 11:15 AM Eastern Time

Location: Room 121

Speaker(s)

JR

James T. Rosenbaum, MD, MACR

Legacy Devers Eye Institute
Portland, OR, United States

Disclosure: Disclosure(s): Abbvie: Consultant (Ongoing); Affibody: Consultant (Ongoing); Celgene-Bristol Myers: Data Safety Monitoring (Ongoing); Corvus: Consultant (Ongoing); Eli Lilly: Outcomes adjudication for clinical trial (Ongoing); Gilead: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Grant/Research Support (Terminated); Priovant: Consultant (Ongoing); Revolo: Consultant (Ongoing); UpToDate: Royalties (Ongoing)